(0)
Capital will enable continued advancement of GenapSys' electronic-based, next-generation sequencing platform
REDWOOD CITY, Calif., May 27, 2021 /PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, and additional new investors. Proceeds from this financing will be used to continue advancing GenapSys' semiconductor based next-generation sequencing (NGS) platform.
"We are delighted to partner with this world-class group of investors who together share our broad strategic vision of delivering an affordable, scalable genomic sequencing ecosystem that empowers both academic and clinical research," said Jason Myers, Ph.D., Chief Executive Officer of GenapSys. "We look forward to leveraging our Board's strategic insight to accelerate new product development, particularly within the oncology arena."